Applied Biosystems Release: Researchers Identify New Protein Biomarker Candidates That May Lead To Better Diagnosis And Treatment For Age-Related Diseases

FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug. 23, 2006-- Applied Biosystems (NYSE: ABI), an Applera Corporation business, and its joint venture partner, MDS Sciex, a division of MDS Inc. (NYSE:MDZ, TSX:MDS), today announced the outcome of the scientific research community's most extensive, spinal fluid-based protein study on neurodegenerative diseases to date. Researchers from the University of Washington, Applied Biosystems and three other research facilities discovered a panel of numerous unique candidate biomarkers that could potentially help develop more effective diagnostic tests and treatments for Alzheimer's disease, Parkinson's disease and Dementia with Lewy Bodies - three age-related diseases that affect more than seven million people in the United States today.(1) The study was published in the August issue of The Journal of Alzheimer's Disease.

Back to news